Cargando…
MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer
BACKGROUND: Cancer cells exhibit an altered metabolism, which is characterized by a preference for aerobic glycolysis more than mitochondrial oxidation of pyruvate. Mitochondrial pyruvate carrier 1 (MPC1) and mitochondrial pyruvate carrier 2 (MPC2) play a bottleneck role by transporting pyruvate int...
Autores principales: | Li, Xiaoli, Ji, Yasai, Han, Gaoyang, Li, Xiaoran, Fan, Zhirui, Li, Yaqing, Zhong, Yali, Cao, Jing, Zhao, Jing, Zhang, Mingzhi, Wen, Jianguo, Goscinski, Mariusz Adam, Nesland, Jahn M., Suo, Zhenhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112705/ https://www.ncbi.nlm.nih.gov/pubmed/27852261 http://dx.doi.org/10.1186/s12885-016-2941-6 |
Ejemplares similares
-
Establishment of mitochondrial pyruvate carrier 1 (MPC1) gene knockout mice with preliminary gene function analyses
por: Li, Xiaoli, et al.
Publicado: (2016) -
PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence
por: Li, Yaqing, et al.
Publicado: (2016) -
Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells
por: Li, Xiaoli, et al.
Publicado: (2017) -
Pyruvate dehydrogenase expression is negatively associated with cell stemness and worse clinical outcome in prostate cancers
por: Zhong, Yali, et al.
Publicado: (2017) -
MPC construction techniques
Publicado: (1971)